Free Trial

Horizon Kinetics Medical ETF Rating

$32.69 +0.14 (+0.43%)
As of 01:55 PM Eastern

Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2026)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

MEDX Aggregate Rating

Moderate Buy
2.65

Holdings in MEDX have an aggregate rating of Moderate Buy based on 391 analyst ratings issued in the past year covering 22 companies (77.1% of the portfolio).

MEDX Aggregate Price Target

$32.69
High Prediction$32.69
Average Prediction$32.69
Low Prediction$32.69

Holdings in MEDX have an aggregate price target of $32.69 and a range of $32.69 to $32.69 covering 22 companies (77.1% of the portfolio).

MEDX Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
Moderate Buy
14 Moderate Buy rating(s)
Hold
5 Hold rating(s)
Reduce
1 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
1 Strong Sell rating(s)

Ratings for Stocks Held by Horizon Kinetics Medical ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 22 MEDX Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
15.38%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$989.02
+2.2%
4.8771 of 5 stars
2.87$1,217.59 23.1%30
7.99%
AbbVie Inc. stock logo
ABBV
AbbVie
$206.12
-1.0%
4.9083 of 5 stars
2.85$252.90 22.7%26
5.71%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$225.59
+0.6%
4.921 of 5 stars
2.67$252.48 11.9%27
5.10%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$56.94
-0.8%
4.7086 of 5 stars
2.37$61.31 7.7%19
4.75%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$75.25
-0.3%
3.5394 of 5 stars
2.86$99.35 32.0%21
4.23%
Amgen Inc. stock logo
AMGN
Amgen
$329.59
+1.8%
4.4701 of 5 stars
2.42$357.12 8.4%31
4.10%
Alkermes plc stock logo
ALKS
Alkermes
$36.25
+6.1%
3.4679 of 5 stars
2.82$44.29 22.2%17
4.03%
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$301.11
+1.1%
4.3421 of 5 stars
2.81$471.96 56.7%26
3.90%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$113.21
+0.1%
4.8114 of 5 stars
2.68$128.18 13.2%19
3.66%
Pfizer Inc. stock logo
PFE
Pfizer
$26.42
+0.5%
3.9753 of 5 stars
2.23$28.74 8.8%22
3.22%
GSK PLC Sponsored ADR stock logo
GSK
GSK
$50.37
-1.0%
3.5856 of 5 stars
1.90$53.00 5.2%10
2.97%
Biogen Inc. stock logo
BIIB
Biogen
$189.13
+1.0%
4.0892 of 5 stars
2.50$214.23 13.3%28
2.84%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$52.38
-2.2%
2.4474 of 5 stars
2.53$64.53 23.2%19
2.83%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$702.45
-1.0%
4.2943 of 5 stars
2.77$826.59 17.7%26
1.48%
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$28.90
-3.9%
2.8862 of 5 stars
2.75$49.36 70.8%16
0.99%
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$13.31
-4.0%
2.8209 of 5 stars
2.35$20.09 50.9%23
0.93%
Vanda Pharmaceuticals Inc. stock logo
VNDA
Vanda Pharmaceuticals
$7.39
-2.2%
2.7821 of 5 stars
2.50$14.90 101.6%8
0.81%
Sandoz Group AG Sponsored ADR stock logo
SDZNY
Sandoz Group
$84.29
+5.3%
2.2624 of 5 stars
3.004
0.70%
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
$9.18
-0.7%
4.328 of 5 stars
2.78$12.33 34.3%9
0.67%
Galectin Therapeutics Inc. stock logo
GALT
Galectin Therapeutics
$2.23
-2.6%
1.2822 of 5 stars
2.00$11.00 393.3%2
0.48%
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$3.04
+1.3%
3.3495 of 5 stars
2.57$5.40 77.6%7
0.37%
Lantern Pharma Inc. stock logo
LTRN
Lantern Pharma
$2.16
-3.1%
0.3394 of 5 stars
1.001

This page (NASDAQ:MEDX) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners